Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Juniperanol: First total synthesis and evaluation in Type 2 Diabetes disease.

Carrër A, Turban S, Provost N, Caliez A, Lamarche G, Zanirato G, Beucher M, Pean C, Mirguet O, Perron-Sierra F, Michelet V.

Bioorg Chem. 2019 Nov;92:103243. doi: 10.1016/j.bioorg.2019.103243. Epub 2019 Sep 5.

PMID:
31518756
2.

Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017.

Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, Mayala BK, VanderHeide JD, Collison ML, Hall JB, Biehl MH, Carter A, Frank T, Douwes-Schultz D, Burstein R, Casey DC, Deshpande A, Earl L, El Bcheraoui C, Farag TH, Henry NJ, Kinyoki D, Marczak LB, Nixon MR, Osgood-Zimmerman A, Pigott D, Reiner RC Jr, Ross JM, Schaeffer LE, Smith DL, Davis Weaver N, Wiens KE, Eaton JW, Justman JE, Opio A, Sartorius B, Tanser F, Wabiri N, Piot P, Murray CJL, Hay SI.

Nature. 2019 Jun;570(7760):189-193. doi: 10.1038/s41586-019-1200-9. Epub 2019 May 15.

3.

Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.

Lefrançois P, Xie P, Wang L, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Wheeler DA, Duvic M, Litvinov IV.

Oncoimmunology. 2018 May 31;7(8):e1467856. doi: 10.1080/2162402X.2018.1467856. eCollection 2018.

4.

Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.

Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Roshdy O, Pehr K, Sasseville D, Litvinov IV.

J Cutan Med Surg. 2018 Mar/Apr;22(2):154-165. doi: 10.1177/1203475417745825. Epub 2017 Dec 14.

PMID:
29241349
5.

Rust-colored patches on the lower extremities: lichen aureus.

Roy SF, Ghazawi FM, Provost N.

Int J Dermatol. 2018 Jan;57(1):77-78. doi: 10.1111/ijd.13830. Epub 2017 Nov 22. No abstract available.

PMID:
29165803
6.

TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.

Lefrançois P, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Duvic M, Litvinov IV.

Front Med (Lausanne). 2017 Sep 22;4:153. doi: 10.3389/fmed.2017.00153. eCollection 2017.

7.

Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina.

Ameline B, Tshilenge KT, Weber M, Biget M, Libeau L, Caplette R, Mendes-Madeira A, Provost N, Guihal C, Picaud S, Moullier P, Pichard V, Cronin T, Isiegas C.

Gene Ther. 2017 Nov;24(11):735-741. doi: 10.1038/gt.2017.63. Epub 2017 Sep 7.

PMID:
28880021
8.

Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.

Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, Netchiporouk E, Pehr K, Prieto VG, Rahme E, Provost N, Gilbert M, Sasseville D, Duvic M.

Oncoimmunology. 2017 Mar 17;6(5):e1306618. doi: 10.1080/2162402X.2017.1306618. eCollection 2017.

9.

Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.

Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Pehr K, Sasseville D, Litvinov IV.

Cancer. 2017 Sep 15;123(18):3550-3567. doi: 10.1002/cncr.30758. Epub 2017 May 10.

10.

Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates.

Tshilenge KT, Ameline B, Weber M, Mendes-Madeira A, Nedellec S, Biget M, Provost N, Libeau L, Blouin V, Deschamps JY, Le Meur G, Colle MA, Moullier P, Pichard V, Rolling F.

Hum Gene Ther Methods. 2016 Jun;27(3):122-34. doi: 10.1089/hgtb.2016.034.

PMID:
27229628
11.

Multiple Xanthogranulomas in an Adult: Known Entity, New Association.

Vadeboncoeur S, Provost N.

J Cutan Med Surg. 2016 Sep;20(5):474-7. doi: 10.1177/1203475416640795. Epub 2016 Mar 22.

PMID:
27006313
12.

Lymphomatoid papulosis and fingolimod-A new connection?

Cohen V, Saber M, Provost N, Friedmann D.

Mult Scler. 2016 Oct;22(12):1629-1630. Epub 2016 Mar 18. No abstract available.

PMID:
26993118
13.

AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs.

Pichard V, Provost N, Mendes-Madeira A, Libeau L, Hulin P, Tshilenge KT, Biget M, Ameline B, Deschamps JY, Weber M, Le Meur G, Colle MA, Moullier P, Rolling F.

Mol Ther. 2016 May;24(5):867-76. doi: 10.1038/mt.2016.37. Epub 2016 Feb 9.

14.

Low WSS Induces Intimal Thickening, while Large WSS Variation and Inflammation Induce Medial Thinning, in an Animal Model of Atherosclerosis.

Millon A, Sigovan M, Boussel L, Mathevet JL, Louzier V, Paquet C, Geloen A, Provost N, Majd Z, Patsouris D, Serusclat A, Canet-Soulas E.

PLoS One. 2015 Nov 17;10(11):e0141880. doi: 10.1371/journal.pone.0141880. eCollection 2015.

15.

Quantification of C. globosum spores in house dust samples.

Shi C, Provost NB, Desroches T, Miller JD.

Ann Agric Environ Med. 2014;21(3):525-30. doi: 10.5604/12321966.1120595.

16.

Diagnostic value of three-dimensional contrast-enhanced echocardiography for left ventricular volume and ejection fraction measurement in patients with poor acoustic windows: a comparison of echocardiography and magnetic resonance imaging.

Saloux E, Labombarda F, Pellissier A, Anthune B, Dugué AE, Provost N, Allain P, De Craene M, Milliez P, Manrique A.

J Am Soc Echocardiogr. 2014 Oct;27(10):1029-40. doi: 10.1016/j.echo.2014.06.006. Epub 2014 Jul 23.

PMID:
25063466
17.

Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy.

Lhériteau E, Petit L, Weber M, Le Meur G, Deschamps JY, Libeau L, Mendes-Madeira A, Guihal C, François A, Guyon R, Provost N, Lemoine F, Papal S, El-Amraoui A, Colle MA, Moullier P, Rolling F.

Mol Ther. 2014 Feb;22(2):265-277. doi: 10.1038/mt.2013.232. Epub 2013 Oct 4.

18.

Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Richer V, Bouffard D, Bélisle A, Duranceau L, Perreault I, Provost N.

Burns. 2013 Sep;39(6):1290-6. doi: 10.1016/j.burns.2013.02.009. Epub 2013 Apr 15.

PMID:
23597847
19.

Signet-ring cell colon cancer in a 19-year-old patient with giant congenital cellular blue nevus of the scalp.

Richer V, Bouffard D, Provost N.

Int J Dermatol. 2013 Aug;52(8):1021-3. doi: 10.1111/j.1365-4632.2011.05068.x. Epub 2013 Apr 4. No abstract available.

PMID:
23557461
20.

Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.

Alexandre J, Saloux E, Dugué AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P, Milliez P.

J Cardiovasc Magn Reson. 2013 Jan 19;15:12. doi: 10.1186/1532-429X-15-12.

21.

Characterization of an antigenic chitosanase from the cellulolytic fungus Chaetomium globosum.

Provost NB, Shi C, She YM, Cyr TD, Miller JD.

Med Mycol. 2013 Apr;51(3):290-9. doi: 10.3109/13693786.2012.715246. Epub 2012 Sep 18.

PMID:
22985087
22.

Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.

Sigovan M, Kaye E, Lancelot E, Corot C, Provost N, Majd Z, Breisse M, Canet-Soulas E.

Invest Radiol. 2012 Sep;47(9):546-52. doi: 10.1097/RLI.0b013e3182631e68.

PMID:
22864378
23.

Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy.

Petit L, Lhériteau E, Weber M, Le Meur G, Deschamps JY, Provost N, Mendes-Madeira A, Libeau L, Guihal C, Colle MA, Moullier P, Rolling F.

Mol Ther. 2012 Nov;20(11):2019-30. doi: 10.1038/mt.2012.134. Epub 2012 Jul 24.

24.

Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris.

Bissonnette R, Maari C, Nigen S, Provost N, Bolduc C.

J Drugs Dermatol. 2010 Nov;9(11):1347-52.

PMID:
21061756
25.

Assessment of age modulated vascular inflammation in ApoE-/- mice by USPIO-enhanced magnetic resonance imaging.

Sigovan M, Bessaad A, Alsaid H, Lancelot E, Corot C, Neyran B, Provost N, Majd Z, Breisse M, Canet-Soulas E.

Invest Radiol. 2010 Nov;45(11):702-7. doi: 10.1097/RLI.0b013e3181f16e5a.

PMID:
20829703
26.

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease.

Aouba A, Georgin-Lavialle S, Pagnoux C, Martin Silva N, Renand A, Galateau-Salle F, Le Toquin S, Bensadoun H, Larousserie F, Silvera S, Provost N, Candon S, Seror R, de Menthon M, Hermine O, Guillevin L, Bienvenu B.

Blood. 2010 Nov 18;116(20):4070-6. doi: 10.1182/blood-2010-04-279240. Epub 2010 Aug 19.

PMID:
20724540
27.

Clinico-pathologic conference: case 6.

Ghannoum JE, Odingo NA, Provost N.

Head Neck Pathol. 2009 Dec;3(4):299-302. doi: 10.1007/s12105-009-0140-3. Epub 2009 Oct 17. No abstract available.

28.

M1-activated macrophages migration, a marker of aortic atheroma progression: a preclinical MRI study in mice.

Bessaad A, Sigovan M, Alsaid H, De Souza G, Provost N, Majd Z, Menager C, Honnorat J, Lagarde F, Nighoghossian N, Nataf S, Canet-Soulas E.

Invest Radiol. 2010 May;45(5):262-9. doi: 10.1097/RLI.0b013e3181d78030.

PMID:
20375846
29.

A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.

Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, Seite S.

J Cosmet Dermatol. 2010 Mar;9(1):16-21. doi: 10.1111/j.1473-2165.2010.00476.x.

PMID:
20367668
30.

Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors.

Lhériteau E, Libeau L, Mendes-Madeira A, Deschamps JY, Weber M, Le Meur G, Provost N, Guihal C, Moullier P, Rolling F.

Mol Ther. 2010 Jun;18(6):1085-93. doi: 10.1038/mt.2010.46. Epub 2010 Mar 30.

31.

Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.

Saber M, Bourassa-Fulop C, Bouffard D, Provost N.

J Cutan Med Surg. 2010 Mar-Apr;14(2):95-9.

PMID:
20338126
32.

A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu.

Peethambaram PP, Melisko ME, Rinn KJ, Alberts SR, Provost NM, Jones LA, Sims RB, Lin LR, Frohlich MW, Park JW.

Clin Cancer Res. 2009 Sep 15;15(18):5937-44. doi: 10.1158/1078-0432.CCR-08-3282. Epub 2009 Sep 1.

33.

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.

Higano CS, Schellhammer PF, Small EJ, Burch PA, Nemunaitis J, Yuh L, Provost N, Frohlich MW.

Cancer. 2009 Aug 15;115(16):3670-9. doi: 10.1002/cncr.24429.

34.

Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris.

Bissonnette R, Bolduc C, Seité S, Nigen S, Provost N, Maari C, Rougier A.

J Cosmet Dermatol. 2009 Mar;8(1):19-23. doi: 10.1111/j.1473-2165.2009.00418.x.

PMID:
19250161
35.

The RPGRIP1-deficient dog, a promising canine model for gene therapy.

Lhériteau E, Libeau L, Stieger K, Deschamps JY, Mendes-Madeira A, Provost N, Lemoine F, Mellersh C, Ellinwood NM, Cherel Y, Moullier P, Rolling F.

Mol Vis. 2009;15:349-61. Epub 2009 Feb 18.

36.

Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept.

Lafaille P, Bouffard D, Provost N.

Arch Dermatol. 2009 Jan;145(1):94-5. doi: 10.1001/archdermatol.2008.526. No abstract available.

PMID:
19153359
37.

Etanercept in the treatment of palmoplantar pustulosis.

Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S.

J Drugs Dermatol. 2008 Oct;7(10):940-6.

PMID:
19112757
38.

Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates.

Stieger K, Schroeder J, Provost N, Mendes-Madeira A, Belbellaa B, Le Meur G, Weber M, Deschamps JY, Lorenz B, Moullier P, Rolling F.

Mol Ther. 2009 Mar;17(3):516-23. doi: 10.1038/mt.2008.283. Epub 2008 Dec 23.

39.

A distinct cutaneous reaction to sorafenib and a multikinase inhibitor.

Joncas V, Sammour R, Krasny M, Bouffard D, Provost N.

Int J Dermatol. 2008 Jul;47(7):767-9. doi: 10.1111/j.1365-4632.2008.03598.x. No abstract available.

PMID:
18613894
40.
41.

Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain.

Stieger K, Colle MA, Dubreil L, Mendes-Madeira A, Weber M, Le Meur G, Deschamps JY, Provost N, Nivard D, Cherel Y, Moullier P, Rolling F.

Mol Ther. 2008 May;16(5):916-23. doi: 10.1038/mt.2008.41. Epub 2008 Mar 11.

42.

Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases.

Stieger K, Mendes-Madeira A, Meur GL, Weber M, Deschamps JY, Nivard D, Provost N, Moullier P, Rolling F.

Gene Ther. 2007 Dec;14(23):1668-73. Epub 2007 Oct 4.

PMID:
17914405
43.

Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.

Rolling F, Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Péréon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F.

Bull Mem Acad R Med Belg. 2006;161(10-12):497-508; discussion 508-9.

PMID:
17503728
44.

Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.

Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Péréon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F.

Gene Ther. 2007 Feb;14(4):292-303. Epub 2006 Oct 5.

PMID:
17024105
45.

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Française pour l'Etude du Foie Groupe Epidémiologie et Evaluation; Association Nationale des Gastroentérologues des Hôpitaux généraux de France.

J Hepatol. 2006 Oct;45(4):592-9. Epub 2006 Jun 16.

PMID:
16837098
46.

Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion.

Alotaibi L, Provost N, Gagnon S, Franco EL, Coutlée F.

J Clin Virol. 2006 Jun;36(2):133-40. Epub 2006 May 5.

PMID:
16678481
47.

Mirror syndrome due to parvovirus B19 hydrops complicated by severe maternal pulmonary effusion.

Brochot C, Collinet P, Provost N, Subtil D.

Prenat Diagn. 2006 Feb;26(2):179-80. No abstract available.

PMID:
16463296
48.

Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.

Stieger K, Le Meur G, Lasne F, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Martin L, Moullier P, Rolling F.

Mol Ther. 2006 May;13(5):967-75. Epub 2006 Jan 25.

49.

Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain.

Provost N, Le Meur G, Weber M, Mendes-Madeira A, Podevin G, Cherel Y, Colle MA, Deschamps JY, Moullier P, Rolling F.

Mol Ther. 2005 Feb;11(2):275-83.

50.

Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle.

Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Joussemet B, Bujard H, Samulski RJ, Favre D, Moullier P.

Mol Ther. 2004 Mar;9(3):410-8.

Supplemental Content

Loading ...
Support Center